Diebold Nixdorf Reports Higher Q4 Revenue and Margin Expansion, Issues 2026 Guidance
Diebold Nixdorf Inc. (NYSE: DBD) reported a robust conclusion to fiscal year 2025, marked by record free cash flow and...
ADVERTISEMENT
Earnings
Lincoln National Closes 2025 With Profit Growth
Lincoln National Corporation (NYSE: LNC) reported consolidated revenue of $4.92 billion for the fourth quarter ending December 31, 2025. This...
RELX Delivers Strong 2025 Results with 7% Underlying Revenue Growth, Eyes Robust 2026 Expansion
RELX (NYSE: RELX), the global provider of information-based analytics and decision tools, reported solid full-year 2025 performance. Underlying revenue grew...
Avient Powers Through 2025 on Non-PFAS Innovation and SEM Momentum, Sets Sights on 2026 Growth
Avient Corporation (NYSE: AVNT) is a specialty materials company supplying advanced engineered polymers, colorants and additives to packaging, consumer, healthcare,...
Earnings Summary – Birkenstock Reports First Quarter 2026 Revenue Growth of 11%
Birkenstock Holding plc, (NYSE: BIRK) a global brand that manufactures footwear products designed to encourage proper foot health and biomechanics....
ECARX Returns to Profit, Eyes $1B Revenue in 2026
ECARX Holdings Inc (NASDAQ: ECX), a Chinese automotive technology company providing vehicle computing platforms, digital cockpits, and software for OEMs,...
Zebra Technologies (ZBRA) Q4 FY25 adj. earnings beat estimates; sales up 11%
Zebra Technologies Corporation (NASDAQ: ZBRA), a provider of AI-driven data-capture and automation solutions, on Thursday reported higher adjusted earnings for...
Howmet Aerospace 2025 Profit Surges 40% as Commercial and Defense Markets Expand
Howmet Aerospace Inc. (NYSE: HWM) reported record financial results for the fourth quarter and full year 2025, driven by a...
Rollins Reports 11% Annual Revenue Growth, But Q4 Margins Narrow
Rollins, Inc. (NYSE: ROL) shares fell more than 13% in extended trading Wednesday after the pest control giant reported fourth-quarter...
West Pharmaceutical Q4 EPS Beats Estimates; Guides 2026 Sales Growth of 5% to 7%
West Pharmaceutical Services, Inc. (NYSE: WST) reported fourth-quarter 2025 financial results on Thursday that exceeded analyst expectations, supported by strong...